Prior influenza vaccine is not a risk of factor for bacterial coinfection in patients admitted to the icu due to severe influenza

Proaños Jurado, Nadia Juliana; Bastidas Goyes, Alirio; Reyes, Luis Felipe

dc.contributor.advisor	Martin Loeches, Ignacio
dc.contributor.advisor	Rodríguez, Alejandro
dc.contributor.author	Proaños Jurado, Nadia Juliana
dc.contributor.author	Bastidas Goyes, Alirio
dc.contributor.author	Reyes, Luis Felipe
dc.date.accessioned	2020-09-28T17:00:30Z
dc.date.available	2020-09-28T17:00:30Z
dc.date.issued	2020-08-14
dc.identifier.uri	http://hdl.handle.net/10818/43364
dc.description	26 páginas	es_CO
dc.description.abstract	Influenza vaccination is the most effective strategy to prevent influenza infection worldwide. Moreover, it can also reduce risk of pneumonia and death due to influenza. Thus, current clinical guidelines recommend annual flu vaccination in healthy individuals. However, recent evidence has shown that influenza vaccines might increases upper respiratory tract bacterial colonization and therefore, there may be an increased risk for bacterial co-infection during influenza disease. However, this has not been tested in realworld evidence.	en
dc.format	application/pdf	es_CO
dc.language.iso	eng	es_CO
dc.publisher	Universidad de La Sabana	es_CO
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.source	Universidad de La Sabana
dc.source	Intellectum Repositorio Universidad de La Sabana
dc.title	Prior influenza vaccine is not a risk of factor for bacterial coinfection in patients admitted to the icu due to severe influenza	en
dc.type	master thesis	es_CO
dc.identifier.local	278440
dc.identifier.local	TE10855
dc.type.hasVersion	publishedVersion	es_CO
dc.rights.accessRights	restrictedAccess	es_CO
dc.subject.armarc	Vacunas	spa
dc.subject.armarc	Vacuna contra la influenza	spa
dc.subject.armarc	Vacunas virales	spa
dcterms.references	Murray, Patrick. Rosenthal, Ken s. Pfaller M. Microbiología Médica. Sexta Edic. (Elsevier Mosby, ed.).; 2013.	eng
dcterms.references	World Health Organization. Fact sheet on seasonal influenza. https://www.who.int/en/newsroom/fact-sheets/detail/influenza-(seasonal). Accessed February 2, 2019.	eng
dcterms.references	Hale BG, Albrecht RA G-SA. Innate immune evasion strategies of influenza viruses. Future Microbiol. Futur Microbiol. 2010;5(1):23-41	eng
dcterms.references	Monto AS, Fukuda K. Lessons From Influenza Pandemics of the Last 100 Years. Clin Infect Dis. 2019:1-27. doi:10.1093/cid/ciz803	eng
dcterms.references	Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM JD. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season. MMWR Recomm. 2018;67(3):1-20. doi:10.15585/mmwr.rr6803a1	eng
dcterms.references	Grohskopf LA, Soklow LZ, Broder KR, Walter EB, Bresee JS, Fry AM JD. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season. MMWR Recomm Rep. 2017;66(2):1-20.	eng
dcterms.references	Influenza (Flu). Centers for Desease Control and Prevention, National Center for Immunization and Respiratory Diseases. https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm. Published 2020. Accessed March 10, 2020.	eng
dcterms.references	Sharma-Chawla N, Sender V, Kershaw O, Gruber AD, Volckmar J, Henriques- Normark B, Stegemann-Koniszewski S BD. Influenza A virus infection predisposes hosts to secondary infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation. Infect Immun. 2016;84(12):3445-3457. doi:10.1128/IAI.00422-16	eng
dcterms.references	Jia L, Xie J, Zhao J, Cao D, Liang Y, Hou X, Wang L LZ. Mechanisms of Severe MortalityAssociated Bacterial Co-infections Following Influenza Virus Infection. Front Cell Infect Microbiol. 2017;7:338.	eng
dcterms.references	Joseph C, Togawa Y SN. Bacterial and viral infections associated with influenza. Influ Other Respir Viruses. 2013;7(2):105-113	eng
dcterms.references	Mina MJ. Generalized herd effects and vaccine evaluation: impact of live influenza vaccine on offtarget bacterial colonisation. J Infect. 2017;74:S101-S107. doi:10.1016/S0163-4453(17)30199-8	eng
dcterms.references	Thors V, Christensen H, Morales-Aza B, Vipond I, Muir P, Finn A. The effects of live attenuated influenza vaccine on nasopharyngeal bacteria in healthy 2 to 4 year olds: A randomized controlled trial. Am J Respir Crit Care Med. 2016;193(12):1401-1409. doi:10.1164/rccm.201510-2000OC	eng
dcterms.references	Martin-Loeches I, J Schultz M, Vincent JL, Alvarez-Lerma F, Bos LD, Solé Violán J, Torres A RA. Increased incidence of co-infection in critically ill patientes with influenza. Intensive Care Med. 2017;43(1):48-58.	eng
dcterms.references	Martin-Corral J, Climent C, Muñoz R et al. Patientes with influenza A (H1N1) pdm09 admitted to the ICU. Impact of the recommendations of the SEMICYUC. Med intensiva. 2018;42:473-481.	eng
dcterms.references	Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis. 2007;44(Supplement_2):S27-S72. doi:10.1086/511159	eng
dcterms.references	Knaus WA, Draper EA, Wagner DP ZJ. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(19):818-829.	eng
dcterms.references	Vincent JL, Moreno R, Takala J et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707-710.	eng
dcterms.references	David W. Hosmer SL. Applied Logistic Regression.; 2000. http://resource.heartonline.cn/20150528/1_3kOQSTg.pdf	eng
dcterms.references	Rubin DB TN. Matching using estimated propensity scores: relating theory to practice. Biometrichs. 1996;52(1):249-264.	eng
dcterms.references	Johnson SR, Tomlinson GA, Hawker GA GJ. Propensity Score Methods for Bias Reduction in Observational Sstudies of Treatment Effect. Rheum Dis Clin North Am. 2018;44(2):203-213.	eng
dcterms.references	PC. A. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivar Behav Res. 2011;46(3):399-424.	eng
dcterms.references	StataCorp. 2015. Stata Statistical Sofware: Release 14. College Station, TX: StataCorp LP	eng
dcterms.references	Resolucion 8430 de 1993.; 1993.	eng
dcterms.references	Chaussee MS, Sandbulte HR, Schuneman MJ, Depaula FP, Addengast LA, Schlenker EH HV. Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections. Vaccine. 2011;29(21):3773-3781.	eng
dcterms.references	Smith AM, Huber VC. The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza. Viral Immunol. 2018;31(2):159-173. doi:10.1089/vim.2017.0138	eng
dcterms.references	Mina MJ, McCullers JA, Klugman KP. Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice. MBio. 2014;5(1):1-10. doi:10.1128/mBio.01040-13	eng
dcterms.references	Lee SE, Eick A, Bloom MS BJ. Influenza immunization and subsequent diagnoses of group A streptococcus-ilnesses among U.S. Army trainees. Vaccine. (27):27-28. doi:doi:10.1016/j.vaccine.2008.04.041	eng
dcterms.references	Trombetta CM, Gianchecchi, E ME. Influenza vaccines: Evaluation of the safety profile. Hum Vaccin Immunother. 2018;14(3):657-670.	eng
dcterms.references	Thomas R. Frieden,. Harold W. Jaffe JC et al. Prevention and control of seasonal influenza with vaccines recomendations of the advisory committe on immunization practices - United states, 2016- 17 Influenza season. Centers Desease Control Prev Morb Mortal Wkly Rep. 2016;65(5). https://www.cdc.gov/mmwr/volumes/65/rr/pdfs/rr6505.pdf.	eng
dcterms.references	Aleem MS, Sexton R AJ. Pneumonia in an Immunocompromised patient. StatPearls.	eng
dcterms.references	Ortqvist A, Hedlund J KM. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Semin Respir Crit Care Med. 2005;26(6):563-574	eng
dcterms.references	Joshi M, Chandra D, Mittadodla P BT. No TitleThe impact of vaccination on influenza-related respiratory failure and mortality in hospitalized elderly patients over the 2013-2014 season. Open Respir Med J. 2015;23(9):9-14.	eng
dcterms.references	Kalil AC, Thomas PG. Influenza virus-related critical illness: Pathophysiology and epidemiology. Crit Care. 2019;23(1):1-7. doi:10.1186/s13054-019-2539-x	eng
dcterms.references	Thompson MG, Pierse N, Sue Huang Q et al. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015. Vaccine. 2018;36(39):5916-5925.	eng
dcterms.references	Morens DM, Taubengberger JK FA. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic Influenza preparedness. J Infect Dis. 2008;198(7):962-970. doi:10.1086/591708	eng
dcterms.references	Rice TW, Rubinson L, Uyeki TM, Vaughn FL, John BB, Miller RR 3rd, Higgs E, Randolph AG, Smoot BE TB. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med. 2012;40(5):1487-1498.	eng
dcterms.references	JA. M. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol. 2006;19(3):571-582.	eng
dcterms.references	Morens DM, Taubenberger JK, Fauci AS. Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness. J Infect Dis. 2008;198(7):962-970. doi:10.1086/591708	eng
dcterms.references	Catania J, Que LG, Govert JA, Holingsworth JW WC. High intensive care unit admission rate for 2013-2014 influenza is associated with a low rate of vaccination. Am J Respir Crit Care. 2014;189(4):485-487	eng
thesis.degree.discipline	Facultad de Medicina	es_CO
thesis.degree.level	Maestría en Epidemiología	es_CO
thesis.degree.name	Magíster en Epidemiología	es_CO